bleeding. Those who underwent reoperation had longer length of stay than those who did not have reoperation (p ¼ 0.0002). The most common indications for reoperation were urinary tract related (63.3%) i.e. cystoscopy or sling re-tensioning, gynecologic, i.e. examination under anesthesia (12.2%), gastrointestinal (8.2%), i.e. endoscopy, and non-infectious wound (8.2%), i.e. suture removal. CONCLUSION: Isolated midurethral sling placement has low readmission and reoperation rates, both being below 1%. Longer operative time was associated with readmission, whereas increased length of stay was associated with both readmission and reoperation. However, these may not be clinically relevant.
OBJECTIVES: To investigate the difference in amount of early postoperative opioid used for pain management after single -port robotic hysterectomy versus multi-port robotic hysterectomy. MATERIALS AND METHODS: This is a retrospective cross-sectional study. Women who underwent robotic hysterectomy during January 2013 to September 2015 were entered in the study. The early postoperative period was divided to 1-3 hours, 3-6 hours, and 6-12 hours. Patients received different opioids including fentanyl, morphine, and Oxycodone. Patient who received non-opioid medicine for pain management were excluded from study. We used an online opioid conversion calculator and converted the amount of opioid to one unit of Oxycodone 5 mg PO as our reference. RESULTS: Eight hundred twenty-four patients were entered into the study. Of these patients, 680 underwent multi-port robotic and 144 obtained single-port robotic hysterectomy. Demographic data is summarized in Table 1 . There was no significant difference in operative time, blood loss, and amount of early postoperative opioid used between the three time sets for multi-ports vs. single-port robotic hysterectomy. Multiple linear regression analysis showed a negative correlation between BMI and the amount of opioid intake during 3-6 hours post operation (Table 2) . Additionally, there was significant negative correlation between total operation time and amount of opioid intake for pain during the 3-6 hours post operation for patients who underwent single-port robotic hysterectomy. CONCLUSION: The amount of opioid intake for pain management during early postoperative period did not differ significantly in women who underwent single-port robotic hysterectomy in comparison with multi-port robotic hysterectomy. 
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MATERIALS AND METHODS:
This was a retrospective cohort study of women who had an abdominal hysterectomy at Christiana Care Health System (CCHS) between January 1, 2007 and December 31, 2013. The first 100 charts with the use of ON-Q (ON-Q group) and the first 100 charts without use of ON-Q (Non-ON-Q group) were selected and reviewed. Data on postoperative narcotic use during the first 24 hours and 48 hours was collected. The total narcotic use was then converted to IV hydromorphone equivalents using an opioid equivalence conversion table. Postoperative pain scores were also collected for the first 48 hours postoperatively. Univariate and multivariate analyses were performed with a P-value of < 0.05 being considered statistically significant. RESULTS: A total of 200 women were identified between January 1, 2007 and December 31, 2013 who met the inclusion criteria. There was a decrease in pain score associated in the ON-Q group on POD #0 (ON-Q group of 4.7 vs. Non-ON-Q group of 5.6, p ¼ 0.008). There was also a significant decrease in total narcotic use on POD #2 in the ON-Q group (ON-Q group at 2.1 mg vs. Non-ON-Q group at 2.9 mg, p ¼ 0.004). No other differences in either pain scores or narcotic use occurred. In the multivariate analysis controlling for patient characteristics, the difference was no longer significant. When patients who had additional surgical procedures to their abdominal hysterectomy were excluded (N ¼ 49), no differences in the usage of narcotics during POD #0 (p ¼ 0.13), during the POD #1 (p ¼ 0.55), or on POD #2 (p ¼ 0.22) were found. CONCLUSION: Our findings show that placement of the ON-Q pump did not have a decrease in postoperative narcotic use or pain scores once additional surgical procedures were controlled. A future study should investigate the research question in a prospective cohort.
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71 Predictors of urinary tract infection and need for sling revision due to obstructive symptoms after sub urethral sling procedures
Urinary tract infection (UTI) is a common complication of urinary incontinence surgery. The objective of this study was to identify risk factors for UTI after a sub urethral sling and to determine if UTI is associated with the need for sling revision due to obstructive symptoms. MATERIALS AND METHODS: Current procedure terminology codes were used to identify surgeries involving a sub urethral sling in the Department of Obstetrics & Gynecology at a single tertiary medical center between January 1, 2012, and December 31, 2014. UTI was defined, within 90 days of the sling procedure, by lower urinary tract symptoms and either a positive culture (>10 5 ) or leukocyte esterase or nitrite positive urinalysis and a positive culture (>10 ˇ 3 ). Voiding dysfunction at hospital discharge was defined as need for intermittent self-catheterization or an indwelling Foley catheter. Revision procedures were identified with review of the medical record and operative notes to confirm whether the procedure was needed for obstruction or mesh erosion. After bivariate analysis to identify candidate variables, multivariable logistic regression models were developed to identify factors independently associated with (1) UTI and (2) the need for sling revision due to obstruction. RESULTS: UTI complicated 25.6% (124/485) of surgeries involving a sub-urethral sling. Voiding dysfunction was experienced by 53.2% (258/485), and sling revision for obstruction was necessary in 3.5% (17/485). In a multivariate model adjusted for surgeon, age, and concomitant procedures, women with UTI were more likely to be a race other than white (OR ¼ 3.03, CI ¼ 1.42-6.47), to require intermittent self-catheterization (OR ¼ 4.70, CI ¼ 2.05-10.76), or to be discharged home with a Foley catheter (OR ¼ 10.69, CI ¼ 3. 77-30.26) . Women who had a UTI were more likely to need a sling revision for obstructive lower urinary tract symptoms than those who did not have UTI symptoms (7.3% vs. 2.2%, p ¼ 0.01). They were no more likely to have a mesh exposure (1.6% vs. 1.9%, p > 0.99) or to require an additional surgery for stress incontinence (1.6% vs. 0.3%, p ¼ 0.16). Adjusted for age and concomitant procedures, factors independently associated with the need for sling revision due to obstructive symptoms were UTI (OR ¼ 3.49, CI ¼ 1.29-9.42) and estimated blood loss greater than 200 cc, the 90th percentile in this cohort (OR ¼ 4.42, CI ¼ 1. 29-15.11) . CONCLUSION: This analysis suggests that UTI, often considered unavoidable after urinary incontinence surgery, is an important metric to consider for quality improvement. A high UTI rate after incontinence surgery may reflect surgical technique that leads to a higher burden of obstructive symptoms.
